The Weekly Litigation News Digest is now live. Subscribe now

IP Verse

Allergan Pharmaceuticals competitive analysis

Loading summary...

Latest oppositions filed by Allergan Pharmaceuticals

Explore patent oppositions filed by Allergan Pharmaceuticals against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Nov 13, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP2800811
Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of TranscriptionCHARPENTIERFeb 11, 2018

Latest patents of Allergan Pharmaceuticals opposed by its competitors

Explore Allergan Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 13, 2025
Patent NumberPublication DateTitleTotal Oppositions
EP3509559
Jul 19, 2023Injectable Gels Comprising Cross-Linked Hyaluronic Acid And Hydroxyapatite, And Methods Of Manufacturing Thereof1
EP3024479
Feb 8, 2023High Potency Pancreatin Pharmaceutical Compositions1
EP3003360
Oct 7, 2020High Potency Pancreatin Pharmaceutical Compositions1
EP2922532
Mar 6, 20195-Aminosalicylic Acid Capsule Formulation1
EP2818160
Nov 8, 2017Enteric Coated, Low-Strength Pancrelipase Formulations1

Latest PTAB cases involving Allergan Pharmaceuticals

Discover the latest PTAB cases involving Allergan Pharmaceuticals, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Allergan Pharmaceuticals with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 13, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
ALLERGAN PHARMACEUTICALS15 - -
CAMULON14 - - -
CHARPENTIER - 18 - -
MATHYS & SQUIRE54 - - -